HOYA Vision Care Lights the Way to the Future of Myopia Management at the GOMCC 2023

Singapore – 3rd October 2023 – HOYA Vision Care, committed to sharing knowledge and technological advances in the myopia field, was delighted to take part in the Global Orthokeratology & Myopia Control Conference (GOMCC) that took place on 26–28 September 2023 in Singapore.


Myopia management is a rapidly developing field, with increasing amounts of new products reaching the market each year. As such, evidence is becoming more and more important to help ensure Eye Care Professionals are equipped with proven and effective treatment solutions available to manage their patients. That’s why HOYA Vision Care hosted a symposium and multiple workshops at the recently concluded GOMCC, where this year’s program covered a plethora of latest research findings, innovative treatment strategies, clinical case studies, and advancements in myopia management.


The symposium Lighting the way: new evidence and advances in myopia management moderated by Pascal Blaser, HOYA’s Global Professional Affairs Manager, aimed to educate Eye Care Professionals on new evidence, that have the potential to reshape the future of myopia management. Professor Saw Seang Mei, Duke-NUS Medical School, Singapore, spoke passionately on the protective role of outdoor time in myopia management and encouraged Eye Care Professionals to recommend outdoor time as part of an effective and holistic myopia management strategy. This talk was followed by Dr. Natalia Vlasak, Global Head of Medical and Scientific Affairs at HOYA Vision Care, who shared emerging evidence regarding the synergistic effects of Defocus Incorporated Multiple Segments spectacle lenses with low-dose atropine eye drops, resulting in better treatment outcomes in myopic children.1, 2


With recent evidence showing emmetropic eye growth as a potential method to gauge the success of myopia management,3 Pascal Blaser presented the latest evidence on this topic in an interactive workshop; including how to incorporate emmetropic eye growth curve using axial biometry in clinical practice. This was followed by a workshop conducted by Dr. Oliver Woo from Australia, Mr. Pak Seong Woon from Malaysia and Dr. May Zhang, Global Head of Professional Affairs & Education at HOYA Vision Care, that focused on the importance of evidence-based practice, particularly on incorporating proven solutions, such as MiYOSMART spectacle lenses, into the clinical setting.


This workshop was a nod to the new MiYOSMART campaign Confidence through Evidence which was launched this autumn. The campaign aims to educate Eye Care Professionals on the importance of evidence in childhood myopia and bring attention to the robust MiYOSMART evidence, which will allow Eye Care Professionals to manage myopia in their everyday clinical practice confidently.


Over 2 million parents across the world have already trusted MiYOSMART since its launch in 2018.4 HOYA Vision Care will continue to help fight and control the growing problem of myopia around the world by continually growing MiYOSMART evidence and sharing industry knowledge in the myopia field.


# # #

Product Disclaimer: MiYOSMART spectacle lenses have not been approved for use in the management of Myopia in all countries, including the U.S., and are not currently available for sale in all countries, including the U.S.

“Together, we can tackle myopia in children”


About HOYA Vision Care

For over 60 years, HOYA Vision Care has been a passionate and global leader in optical technology innovation. As a manufacturer of high quality, high performing eyeglass lenses, HOYA continuously aims to bring the best possible vision care solutions to Eye Care Professionals and their patients around the world. The company supplies lenses in 110 countries with a network of over 17,000 employees and 43 laboratories around the globe.

About HOYA

For further information contact:

HOYA Vision Care PR

Susan Brown


Follow HOYA Vision Care on Linkedin                                     


  1. 1. Nucci P, Lembo A, Schiavetti I, et al. A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS/atropine. PLoS One. 2023;18(2):e0281816.
  2. 2. Huang Z, Chen XF, He T, et al. Synergistic effects of defocus-incorporated multiple segments and atropine in slowing the progression of myopia. Sci Rep. 2022;12(1):22311.
  3. 3. Kaymak H, Graff B, Neller K, et al. Myopia treatment and prophylaxis with defocus incorporated multiple segments spectacle lenses. Ophthalmologe. 2021;118(12):1280-6.
  4. 4. Based on number of MiYOSMART spectacle lenses sold per HOYA sales data on file as of August 2023.